Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject

摘要

The present disclosure provides methods for treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. In some embodiments, the method comprises lowering high sensitivity CRP (hs-CRP) levels in a subject including, for example, a subject with a HbA_1c value of about 5.00%-8.50% or at least about 6.8%.